CN105362675A - 一种治疗粉刺性乳痈的乳膏及其制备方法 - Google Patents
一种治疗粉刺性乳痈的乳膏及其制备方法 Download PDFInfo
- Publication number
- CN105362675A CN105362675A CN201510973792.5A CN201510973792A CN105362675A CN 105362675 A CN105362675 A CN 105362675A CN 201510973792 A CN201510973792 A CN 201510973792A CN 105362675 A CN105362675 A CN 105362675A
- Authority
- CN
- China
- Prior art keywords
- parts
- emulsifiable paste
- radix
- fructus
- grass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000004396 mastitis Diseases 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 59
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 240000002924 Platycladus orientalis Species 0.000 claims abstract description 33
- 240000001432 Calendula officinalis Species 0.000 claims abstract description 20
- 244000044425 Quisqualis indica Species 0.000 claims abstract description 20
- 235000005881 Calendula officinalis Nutrition 0.000 claims abstract description 19
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims abstract description 19
- 241000241413 Propolis Species 0.000 claims abstract description 18
- 229940069949 propolis Drugs 0.000 claims abstract description 18
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 17
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims abstract description 17
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229960003639 laurocapram Drugs 0.000 claims abstract description 17
- 229940041616 menthol Drugs 0.000 claims abstract description 17
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000004006 olive oil Substances 0.000 claims abstract description 17
- 235000008390 olive oil Nutrition 0.000 claims abstract description 17
- 229940032094 squalane Drugs 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 244000025254 Cannabis sativa Species 0.000 claims description 39
- 206010000496 acne Diseases 0.000 claims description 37
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 36
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 28
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 claims description 28
- 239000003921 oil Substances 0.000 claims description 21
- 235000019198 oils Nutrition 0.000 claims description 21
- 208000010392 Bone Fractures Diseases 0.000 claims description 20
- 241000608575 Vespertilio Species 0.000 claims description 20
- 241000282472 Canis lupus familiaris Species 0.000 claims description 19
- 241000283956 Manis Species 0.000 claims description 19
- 210000000582 semen Anatomy 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 17
- NWGKJDSIEKMTRX-MDZDMXLPSA-N Sorbitan oleate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(O)C1OCC(O)C1O NWGKJDSIEKMTRX-MDZDMXLPSA-N 0.000 claims description 14
- 229960002242 chlorocresol Drugs 0.000 claims description 14
- 239000003995 emulsifying agent Substances 0.000 claims description 14
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 14
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 14
- 239000006071 cream Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 230000001476 alcoholic effect Effects 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000004576 sand Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 2
- 239000003610 charcoal Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 38
- 210000004369 blood Anatomy 0.000 abstract description 34
- 230000001737 promoting effect Effects 0.000 abstract description 34
- 230000017531 blood circulation Effects 0.000 abstract description 30
- 230000000694 effects Effects 0.000 abstract description 25
- 229940079593 drug Drugs 0.000 abstract description 20
- 210000000481 breast Anatomy 0.000 abstract description 11
- 230000035699 permeability Effects 0.000 abstract description 5
- 230000008591 skin barrier function Effects 0.000 abstract description 5
- 230000001954 sterilising effect Effects 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 241000489083 Arachniodes speciosa Species 0.000 abstract description 2
- 230000012010 growth Effects 0.000 abstract description 2
- 230000001976 improved effect Effects 0.000 abstract description 2
- 230000003020 moisturizing effect Effects 0.000 abstract description 2
- 239000011347 resin Substances 0.000 abstract description 2
- 229920005989 resin Polymers 0.000 abstract description 2
- 240000004500 Alysicarpus vaginalis Species 0.000 abstract 1
- 244000241796 Christia obcordata Species 0.000 abstract 1
- 244000146493 Cryptotaenia japonica Species 0.000 abstract 1
- 235000004035 Cryptotaenia japonica Nutrition 0.000 abstract 1
- 240000001980 Cucurbita pepo Species 0.000 abstract 1
- 235000009852 Cucurbita pepo Nutrition 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 244000042664 Matricaria chamomilla Species 0.000 abstract 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 abstract 1
- 240000008154 Piper betle Species 0.000 abstract 1
- 235000008180 Piper betle Nutrition 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 244000042430 Rhodiola rosea Species 0.000 abstract 1
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 244000089698 Zanthoxylum simulans Species 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000000341 volatile oil Substances 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 22
- 230000036407 pain Effects 0.000 description 19
- 239000003440 toxic substance Substances 0.000 description 16
- 208000003251 Pruritus Diseases 0.000 description 14
- 231100000614 poison Toxicity 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 201000004624 Dermatitis Diseases 0.000 description 9
- 208000033809 Suppuration Diseases 0.000 description 9
- 208000010668 atopic eczema Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 8
- 230000007803 itching Effects 0.000 description 8
- 239000012567 medical material Substances 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 230000023597 hemostasis Effects 0.000 description 6
- 210000002445 nipple Anatomy 0.000 description 6
- 244000045947 parasite Species 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 206010000269 abscess Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 208000034158 bleeding Diseases 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010070834 Sensitisation Diseases 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000004883 areola Anatomy 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000036765 blood level Effects 0.000 description 4
- 230000000249 desinfective effect Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 230000009885 systemic effect Effects 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 229920000832 Cutin Polymers 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 240000001624 Espostoa lanata Species 0.000 description 3
- 235000009161 Espostoa lanata Nutrition 0.000 description 3
- 206010016717 Fistula Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 230000009172 bursting Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000003890 fistula Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 208000036119 Frailty Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010060710 Galactostasis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 208000031361 Hiccup Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010021531 Impetigo Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- HPTYUNKZVDYXLP-UHFFFAOYSA-N aluminum;trihydroxy(trihydroxysilyloxy)silane;hydrate Chemical compound O.[Al].[Al].O[Si](O)(O)O[Si](O)(O)O HPTYUNKZVDYXLP-UHFFFAOYSA-N 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000001112 coagulating effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 229910052621 halloysite Inorganic materials 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 210000004914 menses Anatomy 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000219317 Amaranthaceae Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 241001116272 Balsaminaceae Species 0.000 description 1
- 206010006223 Breast discharge Diseases 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000002567 Capsicum annuum Nutrition 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241000407877 Combretum Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 241001148765 Dryopteridaceae Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241001180747 Hottea Species 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 241000519740 Ilex rotunda Species 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 206010026730 Mammary duct ectasia Diseases 0.000 description 1
- 206010070314 Mammary fistula Diseases 0.000 description 1
- 241000283967 Manidae Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000024818 Nipple disease Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 206010066170 Plasma cell mastitis Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241001448326 Polygonatum cirrhifolium Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038944 Retracted nipple Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 231100000643 Substance intoxication Toxicity 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000013153 catheter ablation Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000008576 chronic process Effects 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000008718 systemic inflammatory response Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药领域,公开了一种治疗粉刺性乳痈的乳膏及其制备方法,所述乳膏由以下原料制成:独一味、红景天、碎骨红、小狗脊、降香、急性子、救必应、铺地蝙蝠草、鸭儿芹、丝瓜、花椒、柏脂、老虎姜、使君子、山芝麻、穿山甲、狗蚁草、蒟酱叶、金盏菊、赤石脂、地肤子、白鹅膏、茶油、蓝甘菊精油、麦饭石、月桂氮卓酮、角鲨烷、蜂胶、薄荷醇、橄榄油等。本发明与皮肤具有很好的亲和性和渗透性,药物可迅速透过皮肤屏障,提高局部或全身血药浓度,促进药物吸收及发挥作用,直接作用与乳房,使药物直达病灶,其中的药物药效相辅相成,相互增益,君药活血化瘀,使血得以循环,然后清热消肿、杀菌解毒、祛腐生肌、舒敏润肤,可有效治疗粉刺性乳痈。
Description
技术领域
本发明属于中药领域,具体涉及一种治疗粉刺性乳痈的乳膏,本发明还涉及该乳膏的制备方法。
背景技术
粉刺性乳痈,是一种以乳腺导管扩张、浆细胞浸润为病变基础的慢性非细菌性感染的乳腺化脓性疾病。其特点是多在非哺乳期或非妊娠期发病,常有乳头凹陷或溢液,初起肿块多位于乳晕部,化脓溃破后脓中夹有脂质样物质,易反复发作,形成瘘管,经久难愈,全身炎症反应较轻。相当于西医的浆细胞性乳腺炎。
粉刺性乳痈多见于青春期后任何年龄女性,临床报道多见于20-40岁女性,且多在非哺乳期、非妊娠期发病,病人多有先天性乳头全部凹陷或线状部分凹陷。多单侧乳房发病,亦有双侧乳房先后发病,呈慢性经过,病情表现多样,病程长达数月或数年。我们在临床上发现,大部分粉刺性乳痈患者在初诊时伴有脓肿形成,或成而未溃或脓成得溃或反复溃破。观患者乳房局部,肿胀部位皮肉多重垂胀急,深则按之如烂棉不起,浅则光亮如水疱,呼之欲出,破流脓水。
对于本病的治疗,西医临床在该病红肿热痛时期,常使用抗生素治疗,但效果不佳,患者症状常无明显改善,或症状好转后不久再次复发。若使用抗生素治疗无效,肿块范围扩大或红肿溃破、脓肿形成时,西医临床多采用手术将乳腺区段切除或导管切除,严重者甚至做乳房单纯切除手术,对于患者的生理和心理影响较大,患者难以接受。中医治疗该病的药物极少,且基本都为中药汤剂,但中药汤剂需要每天煎药,存在服用不方便的缺点,且中医基本无外用药物进行治疗该病。
发明内容
本发明的目的是针对上述问题,提供一种治疗粉刺性乳痈的乳膏及其制备方法,该乳膏与皮肤具有很好的亲和性和渗透性,促进血液循环,药物可迅速透过皮肤屏障,提高局部或全身血药浓度,促进药物吸收及发挥作用,直接作用于乳房,使药物直达病灶,其中的药物药效相辅相成,相互增益,活血化瘀、清热消肿、杀菌解毒、祛腐生肌、舒敏润肤,可有效治疗粉刺性乳痈。
本发明解决上述问题所采用的技术方案是:
一种治疗粉刺性乳痈的乳膏,由以下原料按重量份制成:独一味20-40份、红景天20-40份、碎骨红20-30份、小狗脊10-20份、降香10-18份、急性子15-25份、救必应10-20份、铺地蝙蝠草6-12份、鸭儿芹6-12份、丝瓜10-20份、花椒4-8份、柏脂8-16份、老虎姜10-20份、使君子4-8份、山芝麻6-10份、穿山甲5-10份、狗蚁草6-10份、蒟酱叶8-16份、金盏菊10-20份、赤石脂4-6份、地肤子10-20份、白鹅膏6-10份、茶油10-20份、蓝甘菊精油1-3份、麦饭石6-12份、月桂氮卓酮8-14份、角鲨烷10-18份、蜂胶8-16份、薄荷醇4-6份、橄榄油4-8份、单硬脂酸甘油酯6-10份、司盘800.2-0.4份、氯甲酚0.05-0.07份、OP乳化剂0.2-0.4份。
进一步的,一种治疗粉刺性乳痈的乳膏,由以下原料按重量份制成:独一味20份、红景天20份、碎骨红20份、小狗脊10份、降香10份、急性子15份、救必应10份、铺地蝙蝠草6份、鸭儿芹6份、丝瓜10份、花椒4份、柏脂8份、老虎姜10份、使君子4份、山芝麻6份、穿山甲5份、狗蚁草6份、蒟酱叶8份、金盏菊10份、赤石脂4份、地肤子10份、白鹅膏6份、茶油10份、蓝甘菊精油1份、麦饭石6份、月桂氮卓酮8份、角鲨烷10份、蜂胶8份、薄荷醇4份、橄榄油4份、单硬脂酸甘油酯6份、司盘800.2份、氯甲酚0.05份、OP乳化剂0.2份。
进一步的,一种治疗粉刺性乳痈的乳膏,由以下原料按重量份制成:独一味30份、红景天30份、碎骨红25份、小狗脊15份、降香14份、急性子20份、救必应15份、铺地蝙蝠草9、鸭儿芹9份、丝瓜15份、花椒6份、柏脂12份、老虎姜15份、使君子6份、山芝麻8份、穿山甲8份、狗蚁草8份、蒟酱叶12份、金盏菊15份、赤石脂5份、地肤子15份、白鹅膏8份、茶油15份、蓝甘菊精油2份、麦饭石9份、月桂氮卓酮11份、角鲨烷14份、蜂胶12份、薄荷醇5份、橄榄油6份、单硬脂酸甘油酯8份、司盘800.3份、氯甲酚0.06份、OP乳化剂0.3份。
进一步的,一种治疗粉刺性乳痈的乳膏,由以下原料按重量份制成:独一味40份、红景天40份、碎骨红30份、小狗脊20份、降香18份、急性子25份、救必应20份、铺地蝙蝠草12份、鸭儿芹12份、丝瓜20份、花椒8份、柏脂16份、老虎姜20份、使君子8份、山芝麻10份、穿山甲10份、狗蚁草10份、蒟酱叶16份、金盏菊20份、赤石脂6份、地肤子20份、白鹅膏10份、茶油20份、蓝甘菊精油3份、麦饭石12份、月桂氮卓酮14份、角鲨烷18份、蜂胶16份、薄荷醇6份、橄榄油8份、单硬脂酸甘油酯10份、司盘800.4份、氯甲酚0.07份、OP乳化剂0.4份。
本发明还提供一种治疗粉刺性乳痈的乳膏的制备方法,包括以下步骤:
(1)将独一味、小狗脊、急性子、鸭儿芹、花椒、使君子、狗蚁草、金盏菊、地肤子研磨粉碎至80目,装入密闭容器,然后加入质量分数为75%的乙醇溶液,乙醇溶液的量以没过混合粉末为准,浸泡并搅拌12h,然后回流提取2h,滤过,收集滤液和滤渣,回收滤液中的乙醇,得到浸提膏I;
(2)将步骤(1)收集的滤渣加入3倍无菌水煎煮2h,滤过,将滤液浓缩成相对密度为50℃时1.20-1.25的浸提膏II;
(3)将穿山甲用沙炒至焦黄并晾凉,丝瓜段烧成炭,与红景天、降香、蒟酱叶、赤石脂、麦饭石一同进行超微粉碎,得到超微粉末;
(4)将碎骨红、救必应、铺地蝙蝠草、老虎姜、山芝麻送入研磨机,加适量无菌水进行研磨,滤过,将所得滤液浓缩成相对密度为50℃时1.20-1.25的稠膏;
(5)将茶油、蜂胶、橄榄油、单硬脂酸甘油酯混合水浴加热至完全融化,然后在顺向搅拌条件下依次加入步骤(1)制得的浸提膏I、步骤(2)制得的浸提膏II、步骤(3)制得的超微粉末、步骤(4)制得的稠膏、柏脂、白鹅膏、月桂氮卓酮、角鲨烷,最后加入蓝甘菊精油、薄荷醇、司盘80、氯甲酚、OP乳化剂,顺向搅拌均匀,至上述油相乳液呈半固体状凝固状态,灌装,即得所述的治疗粉刺性乳痈的乳膏。
进一步的,一种治疗粉刺性乳痈的乳膏的制备方法,步骤(3)超微粉碎后过800目网筛,得到中药超微粉。
进一步的,一种治疗粉刺性乳痈的乳膏的制备方法,步骤(4)研磨后的汁液过600目网筛进行过滤。
使用方法:将患处用医用棉球清理干净后,将本发明的乳膏均匀涂抹至患处及其边缘肌肤处,并用无菌纱布覆盖,每日两次,早晚各一次。
药理作用:
独一味:入药部位为唇形科植物独一味的干燥地上部分。味甘、苦,性平。归肝经。有活血止血,祛风止痛的作用。用于跌打损伤,外伤出血,风湿痹痛,黄水病。无瘀滞及孕妇勿服;红景天:入药部位为景天科大花红景天的干燥根和根茎。味甘、苦,性平。归肺、心经。益气活血,通脉平喘。用于气虚血瘀,胸痹心痛,中风偏瘫,倦怠气喘;碎骨红:药源基础为杜鹃花科植物广东的根。甘,苦,性凉。活血散瘀,消肿止痛。主跌打损伤;小狗脊:药源基础是鳞毛蕨科植物美观复叶耳蕨的根茎。清热解毒,祛风止痒,活血散瘀。主热泻,风疹,跌打瘀肿;降香:入药部位为豆科植物降香檀树干和根的干燥心材。辛,温。归肝、脾经。化瘀止血,理气止痛。用于吐血,衄血,外伤出血,肝郁胁痛,胸痹刺痛,跌扑伤痛,呕吐腹痛;急性子:药源基础为凤仙花科植物凤仙花的干燥成熟种子。味微苦、辛,性温。归肺、肝经。破血,软坚,消积。用于症瘕痞块,经闭,噎膈。孕妇慎用;救必应:药源基础为冬青科冬青属植物铁冬青的树皮(二层皮),叶、根也可入药。性寒,味苦。归肺、肝、大肠经。清热解毒,利湿,止痛。用于感冒发热,咽喉肿痛,胃痛,暑湿泄泻,黄疸,痢疾,跌打损伤,风湿痹痛,湿疹,疮疖;铺地蝙蝠草:豆科蝙蝠草属植物铺地蝙蝠草,全草或根可入药。苦、辛,寒。利水通淋,散瘀,解毒。用于小便淋痛,淋证,水肿,吐血,咳血,跌打损伤,疮疡,疥癣,蛇虫咬伤;鸭儿芹:伞形科植物鸭儿芹,全草入药。辛、苦,平。消炎清热,解毒,活血消肿。用于肺热咳喘,肺痈,淋证,疝气,风火牙痛,痈疽疔肿,缠腰火丹,皮肤瘙痒;丝瓜:入药部位为葫芦科植物丝瓜和粤丝瓜的鲜嫩果实;或霜后干枯的老熟果实(天骷髅)。味甘,性凉。归肺、肝、胃、大肠经。清热化痰,凉血解毒。用于热病身热烦渴,咳嗽痰喘,肠风下血,痔疮出血,血淋,崩漏,痈疽疮疡,乳汁不通,无名肿毒,水肿;花椒:入药部位为芸香科植物青椒或花椒的干燥成熟果皮。味辛,性温。归脾、胃、肾经。温中止痛,杀虫止痒。用于脘腹冷痛,呕吐泄泻,虫积腹痛;外用:湿疹,阴痒;柏脂:为柏科植物侧柏树干或树枝经燃烧后分泌的树脂。甘,性平。除温清热,解毒杀虫。主治疥癣,癞疮,秃疮,黄水疮,丹毒,赘疣;老虎姜:药源基础为百合科植物卷叶黄精的根茎。甘辛,平。润肺养阴,健脾益气,祛痰止血,消肿解毒。治虚痨咳嗽,头昏,食少,遗精,盗汗,崩漏带下,产后体亏,吐血,衄血,外伤出血,咽喉肿痛,疮肿,瘰疬;使君子:入药部位为使君子科植物使君子的干燥成熟果实。甘,温。归脾、胃经。杀虫消积。用于蛔虫病,蛲虫病,虫积腹痛,小儿疳积。大量服用可致呃逆、眩晕、呕吐、腹泻等反应。若与热茶同服,亦能引起呃逆、腹泻,故服用时忌饮浓茶;山芝麻:药源基础为梧桐科植物山芝麻的全株。辛微苦,凉。入胃经。清热利湿,通利血脉,解表清热,消肿解毒。治感冒发热、头痛、口渴、痄腮、麻疹、痢疾、肠炎、痈肿、瘰疬、疮毒、湿疹、痔疮;穿山甲:入药部位为鲮鲤科动物穿山甲的鳞甲。味咸,性微寒。归肝、胃经。活血消症,通经下乳,消肿排脓,搜风通络。用于经闭癓瘕,乳汁不通,痈肿疮毒,风湿痹痛,中风瘫痪,麻木拘挛。孕妇慎用;痈肿已溃者忌用;狗蚁草:豆科狗蚁草,以全草、根、叶入药。甘、苦,平。活血通络,清热化湿,驳骨消肿,去腐生肌。主治半身不遂,股骨酸痛,慢性肝炎,蛇咬伤,跌打损伤,骨折,外伤出血,疮疡溃烂久不收口;蒟酱叶:为胡椒科植物蒟酱的叶。辛,温。祛风燥湿,杀虫止痒。治风寒咳嗽、胃痛,风毒脚气,子肿,疥癞,湿疹,脚癣,烫伤;金盏菊:菊科金盏菊,以根、花入药。淡,平。根:活血散瘀,行气利尿。主治症瘕疝气,胃寒疼痛。花:凉血,止血。主治肠风便血。花、叶有消炎、抗菌作用,特别是对葡萄球菌、链球菌效果较好。外用于皮肤、粘膜的各种炎症;赤石脂:为硅酸盐类矿物多水高岭石族多水高岭石,主含四水硅酸铝。味甘、酸、涩,性温。归大肠、胃经。涩肠,止血,生肌敛疮。用于久泻久痢,大便出血,崩漏带下;外治疮疡久溃不敛,湿疮脓水浸淫;地肤子:入药部位为藜科植物地肤子的干燥成熟果实。味辛、苦,性寒。归肾、膀胱经。清热利湿,祛风止痒。用于小便涩痛,阴痒带下,风疹,湿疹,皮肤瘙痒。内无湿热,小便过多者忌服;白鹅膏:从鸭科动物家鹅的脂肪提炼而成。其主要化学成份为甘油三油酸酯、甘油三棕搁酸酯、甘油三硬脂酸酯等。味甘;性凉。归心,小肠经。润皮肤,解毒肿。主治皮肤皴裂,耳聋,聤耳,噎膈反胃,药物中毒,痈肿,疥癣;蓝甘菊精油:对肌肤:改善肌肤之烫伤,水泡,发炎,面疱,湿疹现象。对身体:用于气喘,贫血,烧伤,皮肤炎,消化不良,失眠等功效。薰蒸:具有抗兴奋的与镇静的效果。还具有消除红肿,平复破裂微红管,神经痛,风湿痛,牙痛等现象。
古人云:“女子乳头属肝,乳房属胃”。乳头为足厥阴肝经所属,乳房为足阳明胃经所循,因此本病与肝胃二经关系密切,素有乳头凹陷畸形,加之肝郁气滞,营血不从,凝结成块,久郁化热,肉腐成脓肿,溃后成痿,还与冲任失调、外感邪实有关。禀赋不足是其本虚,七情内伤,冲任失调,外感邪实,致气血运行失调,气血瘀滞,凝结成块,久郁化热,肉腐成脓,是其标实。本发明人根据其标实病因,从临床实践出发,进行了多年的试验摸索,经各种配方反复复配及螯合,研制出一种外用乳膏,以活血化瘀、清热消肿、杀菌解毒、祛腐生肌、舒敏润肤为治则,来治疗粉刺性乳痈。
方中,独一味、红景天、碎骨红、小狗脊、降香共为君药,其中独一味有活血止血,祛风止痛的作用,红景天益气活血,通脉平喘,碎骨红活血散瘀,消肿止痛,小狗脊清热解毒,祛风止痒,活血散瘀,降香化瘀止血,理气止痛,针对气血运行失调,气血瘀滞,凝结成块,久郁化热的病因,此五味药合用具有活血化瘀、清热解毒、祛风止痛的作用;急性子破血,软坚,消积,救必应清热解毒,利湿,止痛,铺地蝙蝠草利水通淋,散瘀,解毒,鸭儿芹消炎清热,解毒,活血消肿,丝瓜清热化痰,凉血解毒,共为臣药,辅助君药活血化瘀、清热消肿;花椒温中止痛,杀虫止痒,柏脂除温清热,解毒杀虫,老虎姜祛痰止血,消肿解毒,使君子杀虫消积,山芝麻清热利湿,通利血脉,解表清热,消肿解毒,此五味药合用具有清热解毒、杀菌止痒的功效,清热毒、消脓肿,并杀菌杀虫消除肉腐成脓滋生的细菌,防止继续恶化,共为佐药;穿山甲活血消症,通经下乳,消肿排脓,搜风通络,狗蚁草活血通络,清热化湿,驳骨消肿,去腐生肌,蒟酱叶祛风燥湿,杀虫止痒,金盏菊有活血散瘀、消炎、抗菌作用,赤石脂生肌敛疮,地肤子清热利湿,祛风止痒,白鹅膏润皮肤,解毒肿,共为使药,清热燥湿、消肿排脓,防止患处继续恶化,杀菌止痒、祛腐生肌、舒敏润肤以消除久郁导致的脓疮,使皮肤恢复。本发明配方按照君臣佐使原则,其中的药物药效相辅相成,相互增益,血是运送营养物质的基础,气是营养物质产生的动力,所以君药活血化瘀,使血得以循环,然后清热消肿、杀菌解毒、祛腐生肌、舒敏润肤,可有效治疗粉刺性乳痈。
方中还有茶油、橄榄油作为基础油,与皮肤亲和力好,极易被皮肤吸收,麦饭石多孔、具有巨大表面积,赋予了本发明乳膏具有很强的吸附作用和交换作用,月桂氮卓酮为非极性透皮促进剂,它可使角质软化,增强通透性,使药物透过皮肤屏障,提高局部或全身血药浓度,提高制剂生物利用度,对亲脂性亲水性药物均有透皮促进作用,角鲨烷化学稳定性高,使用感极佳的动物油脂,对皮肤有较好的亲和性,不会引起过敏和刺激,并能加速配方中其他活性成分向皮肤中渗透,还可抑制霉菌的生长,蜂胶含有丰富而独特的生物活性物质,使其具有抗菌、消炎、止痒、抗氧化、增强免疫、降血糖、降血脂、抗肿瘤等多种功能,薄荷醇具有局部止痒、止痛、清凉、轻微局麻、促渗透等作用,蓝甘菊精油具有消除红肿、镇静的作用,且蜂胶与茶油和橄榄油的配比正合适,使本发明乳膏不油腻、不干燥,易于涂抹均匀,不易脱落。以这些材料作为基质,使得本发明制备的乳膏不油腻、不干燥,可以涂抹在皮肤上不易脱落,清理方便,且对皮肤有较好的亲和性,不易过敏,可使角质软化,增强通透性,使药物透过皮肤屏障,促进血液循环,提高局部或全身血药浓度,促进药物吸收及发挥作用,药物利用率高。
本发明的制备方法中,将独一味、小狗脊、急性子、鸭儿芹、花椒、使君子、狗蚁草、金盏菊、地肤子粉碎后用乙醇溶液浸泡一段时间后,药材变软,细胞膨胀,有效成分容易被煎出,并且药材含有淀粉、蛋白质,经浸泡后,防止在煎煮时,药材表面的淀粉糊化,蛋白质凝固,堵塞药材表面的毛细孔道,使在煎煮时水分进不去,有效成分不易被煎出,影响药物疗效,且可以改变药物的刺激性作用;其滤过的药渣再加无菌水进行煎煮,可充分提取药物中的有效成分;将穿山甲、丝瓜处理后,与红景天、降香、蒟酱叶、赤石脂、麦饭石一同进行超微粉碎,以粉末入药,将碎骨红、救必应、铺地蝙蝠草、老虎姜、山芝麻研磨成汁液入药,可最大限度保留其中的有效成分,更大限度的发挥其功效;最后将所有成分依次加入,顺时针搅拌使乳膏各种成分混合更均匀。
本发明的有益效果:
(1)本发明针对粉刺性乳痈的病因病理,从临床实践出发,进行了多年的试验摸索,经各种配方反复复配及螯合,配药严谨,将多种具有不同功效的天然成分组合到一起,通过简单的工艺进行复配,使用本发明的配方并按照相应的配比和制备方法制备出一种治疗粉刺性乳痈的乳膏,直接作用与乳房,使药物直达病灶,其中的药物药效相辅相成,相互增益,君药活血化瘀,使血得以循环,然后清热消肿、杀菌解毒、祛腐生肌、舒敏润肤,可有效治疗粉刺性乳痈。
(2)本发明以茶油、蓝甘菊精油、麦饭石、月桂氮卓酮、角鲨烷、蜂胶、薄荷醇、橄榄油等作为基质,使得本发明制备的乳膏不油腻、不干燥,可以涂抹在皮肤上不易脱落,清理方便,且对皮肤有较好的亲和性,不易过敏,可使角质软化,增强通透性,使药物透过皮肤屏障,具有很强的吸附作用和交换作用,促进血液循环,提高局部或全身血药浓度,促进药物吸收及发挥作用,药物利用率高。
(3)本发明的制备方法中,将独一味、小狗脊、急性子、鸭儿芹、花椒、使君子、狗蚁草、金盏菊、地肤子粉碎后用乙醇溶液浸泡一段时间后,药材变软,细胞膨胀,有效成分容易被煎出,并且药材含有淀粉、蛋白质,经浸泡后,防止在煎煮时,药材表面的淀粉糊化,蛋白质凝固,堵塞药材表面的毛细孔道,使在煎煮时水分进不去,有效成分不易被煎出,影响药物疗效,且可以改变药物的刺激性作用;其滤过的药渣再加无菌水进行煎煮,可充分提取药物中的有效成分;将穿山甲、丝瓜处理后,与红景天、降香、蒟酱叶、赤石脂、麦饭石一同进行超微粉碎,以粉末入药,将碎骨红、救必应、铺地蝙蝠草、老虎姜、山芝麻研磨成汁液入药,可最大限度保留其中的有效成分,更大限度的发挥其功效;最后将所有成分依次加入,顺时针搅拌使乳膏各种成分混合更均匀。
具体实施方式
下面将结合本发明的实施例,对本发明的技术方案进行清楚、完整地描述。
实施例1
一种治疗粉刺性乳痈的乳膏,由以下原料按重量份制成:独一味20份、红景天20份、碎骨红20份、小狗脊10份、降香10份、急性子15份、救必应10份、铺地蝙蝠草6份、鸭儿芹6份、丝瓜10份、花椒4份、柏脂8份、老虎姜10份、使君子4份、山芝麻6份、穿山甲5份、狗蚁草6份、蒟酱叶8份、金盏菊10份、赤石脂4份、地肤子10份、白鹅膏6份、茶油10份、蓝甘菊精油1份、麦饭石6份、月桂氮卓酮8份、角鲨烷10份、蜂胶8份、薄荷醇4份、橄榄油4份、单硬脂酸甘油酯6份、司盘800.2份、氯甲酚0.05份、OP乳化剂0.2份。
所述治疗粉刺性乳痈的乳膏的制备方法,包括以下步骤:
(1)将独一味、小狗脊、急性子、鸭儿芹、花椒、使君子、狗蚁草、金盏菊、地肤子研磨粉碎至80目,装入密闭容器,然后加入质量分数为75%的乙醇溶液,乙醇溶液的量以没过混合粉末为准,浸泡并搅拌12h,然后回流提取2h,滤过,收集滤液和滤渣,回收滤液中的乙醇,得到浸提膏I;
(2)将步骤(1)收集的滤渣加入3倍无菌水煎煮2h,滤过,将滤液浓缩成相对密度为50℃时1.20-1.25的浸提膏II;
(3)将穿山甲用沙炒至焦黄并晾凉,丝瓜段烧成炭,与红景天、降香、蒟酱叶、赤石脂、麦饭石一同进行超微粉碎,过800目网筛,得到超微粉末;
(4)将碎骨红、救必应、铺地蝙蝠草、老虎姜、山芝麻送入研磨机,加适量无菌水进行研磨,过600目网筛进行过滤,将所得滤液浓缩成相对密度为50℃时1.20-1.25的稠膏;
(5)将茶油、蜂胶、橄榄油、单硬脂酸甘油酯混合水浴加热至完全融化,然后在顺向搅拌条件下依次加入步骤(1)制得的浸提膏I、步骤(2)制得的浸提膏II、步骤(3)制得的超微粉末、步骤(4)制得的稠膏、柏脂、白鹅膏、月桂氮卓酮、角鲨烷,最后加入蓝甘菊精油、薄荷醇、司盘80、氯甲酚、OP乳化剂,顺向搅拌均匀,至上述油相乳液呈半固体状凝固状态,灌装,即得所述的治疗粉刺性乳痈的乳膏。
使用方法:将患处用医用棉球清理干净后,将本发明的乳膏均匀涂抹至患处及其边缘肌肤处,并用无菌纱布覆盖,每日两次,早晚各一次。
实施例2
一种治疗粉刺性乳痈的乳膏,由以下原料按重量份制成:独一味30份、红景天30份、碎骨红25份、小狗脊15份、降香14份、急性子20份、救必应15份、铺地蝙蝠草9、鸭儿芹9份、丝瓜15份、花椒6份、柏脂12份、老虎姜15份、使君子6份、山芝麻8份、穿山甲8份、狗蚁草8份、蒟酱叶12份、金盏菊15份、赤石脂5份、地肤子15份、白鹅膏8份、茶油15份、蓝甘菊精油2份、麦饭石9份、月桂氮卓酮11份、角鲨烷14份、蜂胶12份、薄荷醇5份、橄榄油6份、单硬脂酸甘油酯8份、司盘800.3份、氯甲酚0.06份、OP乳化剂0.3份。
本实施例的制备方法和使用方法与实施例1相同。
实施例3
一种治疗粉刺性乳痈的乳膏,由以下原料按重量份制成:独一味40份、红景天40份、碎骨红30份、小狗脊20份、降香18份、急性子25份、救必应20份、铺地蝙蝠草12份、鸭儿芹12份、丝瓜20份、花椒8份、柏脂16份、老虎姜20份、使君子8份、山芝麻10份、穿山甲10份、狗蚁草10份、蒟酱叶16份、金盏菊20份、赤石脂6份、地肤子20份、白鹅膏10份、茶油20份、蓝甘菊精油3份、麦饭石12份、月桂氮卓酮14份、角鲨烷18份、蜂胶16份、薄荷醇6份、橄榄油8份、单硬脂酸甘油酯10份、司盘800.4份、氯甲酚0.07份、OP乳化剂0.4份。
本实施例的制备方法和使用方法与实施例1相同。
实施例4抑菌试验
1)实验菌种:金黄色葡萄球菌、大肠杆菌。
2)菌种培养基:牛肉膏蛋白胨培养基。
3)抑菌实验采用本发明的长效抑菌保湿唇蜜。
4)具体实验步骤:
(1)制备菌液:将上述两组菌种分别接种于牛肉膏蛋白胨培养基上,在37℃下培养24小时,用接种环挑取少许菌体与装有无菌生理盐水的试管中,震荡均匀,制成菌悬液;
(2)取本发明的乳膏10g融化后,置于无菌培养皿中,备用;
(3)将步骤(1)制成的菌悬液0.1ml置于步骤(2)的培养皿中,混合均匀。
(4)实验结果:
抑菌率计算方法:抑菌率=(总菌落数-剩余菌落数)/总菌落数*100%
观测测量完毕后,将上述培养皿均置于无菌条件下静置两天,跟踪观察发现,培养皿中菌落无变化,说明本发明乳膏具有很好的杀菌能力,且具有较长时间的抑菌性能。
实施例5过敏试验
取健康小鼠30只,体重18-22g,雌雄兼用,试验前剔除背毛,剔除面积3×3cm,随机分为试验组、空白对照组和阳性对照组,每组10只。阳性对照组用2,4-二硝基氯苯,致敏用1%浓度,激发用0.1%浓度;试验组用本发明实施例2的乳膏。取本发明实施例2的乳膏涂于背部去毛区,隔日1次,共3次。于末次接触后14天,在背部同一区域涂抹该,6h后去除药品后即刻观察,并于24、48、72h观察有无过敏反应。空白对照组和阳性对照组用同法激发接触和观察。试验结果:阳性对照组动物皮肤在致敏1小时后即出现局限性红斑和轻微水肿,24小时过敏反应症状加重,致敏率为100%,试验组和空白对照组动物皮肤均未出现任何过敏反应症状,致敏率为0%。实验结果表明本发明的配方温和无刺激,可放心使用。
实施例6临床实验
(1)临床资料
为进一步考察本发明乳膏的临床疗效和安全性,选取86例患有粉刺性乳痈的患者对本发明的疗效进行临床观察。患者均符合《中医病症诊断疗效标准》的诊断标准,可以确诊为粉刺性乳痈。
发病以一侧乳晕部较为多见,亦有双侧同时发病。患者常伴有乳头内缩史,在凹陷的乳头内可有带臭味的渣样物质分泌。少数病人伴有乳头溢液,呈血性或水样。
乳晕旁有结块疼痛,皮色微红,约7~10天成脓。溃后脓液带有臭咪,久不收口,或愈合后又复发。化脓时有发热、头痛。
反复发作,可致疤痕形成,在乳晕部出现僵硬之肿块,且与皮肤粘连。
溃后久不收口,形成乳漏,其特征是用球头银丝从疮孔中深入,可从乳头中穿出。
(2)治疗方法
使用方法:将患处用医用棉球清理干净后,将本发明的乳膏均匀涂抹至患处及其边缘肌肤处,并用无菌纱布覆盖,每日两次,早晚各一次。
十天为一个疗程,治疗两个疗程后记录结果。
(3)诊断标准
参照《中医病症诊断疗效标准》的疗效标准制定。
治愈:肿块消失,疹管愈合。
好转:红热疼痛消失,肿块缩小,瘦瘘近愈。
未愈:肿块不消,瘘管不愈。
(4)治疗结果
从上面治疗结果看,本发明的治愈率为48.84%,有效率为100%,可有效治疗粉刺性乳痈,且在治疗过程中无其他任何不良反应发生。
以上所述是本发明的优选实施方式,其目的在于让熟悉此项技术的人了解本发明内容并加以实施,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也视为本发明的保护范围。
Claims (7)
1.一种治疗粉刺性乳痈的乳膏,其特征在于,由以下原料按重量份制成:独一味20-40份、红景天20-40份、碎骨红20-30份、小狗脊10-20份、降香10-18份、急性子15-25份、救必应10-20份、铺地蝙蝠草6-12份、鸭儿芹6-12份、丝瓜10-20份、花椒4-8份、柏脂8-16份、老虎姜10-20份、使君子4-8份、山芝麻6-10份、穿山甲5-10份、狗蚁草6-10份、蒟酱叶8-16份、金盏菊10-20份、赤石脂4-6份、地肤子10-20份、白鹅膏6-10份、茶油10-20份、蓝甘菊精油1-3份、麦饭石6-12份、月桂氮卓酮8-14份、角鲨烷10-18份、蜂胶8-16份、薄荷醇4-6份、橄榄油4-8份、单硬脂酸甘油酯6-10份、司盘800.2-0.4份、氯甲酚0.05-0.07份、OP乳化剂0.2-0.4份。
2.如权利要求1所述的一种治疗粉刺性乳痈的乳膏,其特征在于,由以下原料按重量份制成:独一味20份、红景天20份、碎骨红20份、小狗脊10份、降香10份、急性子15份、救必应10份、铺地蝙蝠草6份、鸭儿芹6份、丝瓜10份、花椒4份、柏脂8份、老虎姜10份、使君子4份、山芝麻6份、穿山甲5份、狗蚁草6份、蒟酱叶8份、金盏菊10份、赤石脂4份、地肤子10份、白鹅膏6份、茶油10份、蓝甘菊精油1份、麦饭石6份、月桂氮卓酮8份、角鲨烷10份、蜂胶8份、薄荷醇4份、橄榄油4份、单硬脂酸甘油酯6份、司盘800.2份、氯甲酚0.05份、OP乳化剂0.2份。
3.如权利要求1所述的一种治疗粉刺性乳痈的乳膏,其特征在于,由以下原料按重量份制成:独一味30份、红景天30份、碎骨红25份、小狗脊15份、降香14份、急性子20份、救必应15份、铺地蝙蝠草9、鸭儿芹9份、丝瓜15份、花椒6份、柏脂12份、老虎姜15份、使君子6份、山芝麻8份、穿山甲8份、狗蚁草8份、蒟酱叶12份、金盏菊15份、赤石脂5份、地肤子15份、白鹅膏8份、茶油15份、蓝甘菊精油2份、麦饭石9份、月桂氮卓酮11份、角鲨烷14份、蜂胶12份、薄荷醇5份、橄榄油6份、单硬脂酸甘油酯8份、司盘800.3份、氯甲酚0.06份、OP乳化剂0.3份。
4.如权利要求1所述的一种治疗粉刺性乳痈的乳膏,其特征在于,由以下原料按重量份制成:独一味40份、红景天40份、碎骨红30份、小狗脊20份、降香18份、急性子25份、救必应20份、铺地蝙蝠草12份、鸭儿芹12份、丝瓜20份、花椒8份、柏脂16份、老虎姜20份、使君子8份、山芝麻10份、穿山甲10份、狗蚁草10份、蒟酱叶16份、金盏菊20份、赤石脂6份、地肤子20份、白鹅膏10份、茶油20份、蓝甘菊精油3份、麦饭石12份、月桂氮卓酮14份、角鲨烷18份、蜂胶16份、薄荷醇6份、橄榄油8份、单硬脂酸甘油酯10份、司盘800.4份、氯甲酚0.07份、OP乳化剂0.4份。
5.权利要求1-4任一项所述的治疗粉刺性乳痈的乳膏的制备方法,其特征在于,包括以下步骤:
(1)将独一味、小狗脊、急性子、鸭儿芹、花椒、使君子、狗蚁草、金盏菊、地肤子研磨粉碎至80目,装入密闭容器,然后加入质量分数为75%的乙醇溶液,乙醇溶液的量以没过混合粉末为准,浸泡并搅拌12h,然后回流提取2h,滤过,收集滤液和滤渣,回收滤液中的乙醇,得到浸提膏I;
(2)将步骤(1)收集的滤渣加入3倍无菌水煎煮2h,滤过,将滤液浓缩成相对密度为50℃时1.20-1.25的浸提膏II;
(3)将穿山甲用沙炒至焦黄并晾凉,丝瓜煅烧成炭,与红景天、降香、蒟酱叶、赤石脂、麦饭石一同进行超微粉碎,得到超微粉末;
(4)将碎骨红、救必应、铺地蝙蝠草、老虎姜、山芝麻送入研磨机,加适量无菌水进行研磨,滤过,将所得滤液浓缩成相对密度为50℃时1.20-1.25的稠膏;
(5)将茶油、蜂胶、橄榄油、单硬脂酸甘油酯混合水浴加热至完全融化,然后在顺向搅拌条件下依次加入步骤(1)制得的浸提膏I、步骤(2)制得的浸提膏II、步骤(3)制得的超微粉末、步骤(4)制得的稠膏、柏脂、白鹅膏、月桂氮卓酮、角鲨烷,最后加入蓝甘菊精油、薄荷醇、司盘80、氯甲酚、OP乳化剂,顺向搅拌均匀,至上述油相乳液呈半固体状凝固状态,灌装,即得所述的治疗粉刺性乳痈的乳膏。
6.如权利要求5所述的治疗粉刺性乳痈的乳膏的制备方法,其特征在于,步骤(3)超微粉碎后过800目网筛,得到中药超微粉。
7.如权利要求5所述的治疗粉刺性乳痈的乳膏的制备方法,其特征在于,步骤(4)研磨后的汁液过600目网筛进行过滤。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510973792.5A CN105362675A (zh) | 2015-12-22 | 2015-12-22 | 一种治疗粉刺性乳痈的乳膏及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510973792.5A CN105362675A (zh) | 2015-12-22 | 2015-12-22 | 一种治疗粉刺性乳痈的乳膏及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105362675A true CN105362675A (zh) | 2016-03-02 |
Family
ID=55365624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510973792.5A Pending CN105362675A (zh) | 2015-12-22 | 2015-12-22 | 一种治疗粉刺性乳痈的乳膏及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105362675A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107569556A (zh) * | 2017-10-07 | 2018-01-12 | 南京正宽医药科技有限公司 | 一种乳腺炎护理药物组合物及其制备方法 |
| CN118045022A (zh) * | 2024-01-03 | 2024-05-17 | 广州润华生命科学有限公司 | 一种具有促渗透功效的植物组合物及其制备方法和应用 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110778A (zh) * | 2013-02-21 | 2013-05-22 | 遵义市时慧母婴保健护理有限公司 | 一种治疗急性乳腺炎的外用中药散剂配方及制备方法 |
| CN103860855A (zh) * | 2014-03-01 | 2014-06-18 | 王树军 | 一种用于治疗乳痈的中药 |
| CN104288700A (zh) * | 2014-10-27 | 2015-01-21 | 合肥丰瑞隆生物科技有限公司 | 一种治疗乳腺炎的外敷中药 |
| CN104623220A (zh) * | 2015-03-09 | 2015-05-20 | 崔合芳 | 一种治疗乳痈的中药组合物及其应用 |
| CN104623612A (zh) * | 2015-03-09 | 2015-05-20 | 王艳君 | 一种治疗乳痈的活血化瘀药及制备方法 |
-
2015
- 2015-12-22 CN CN201510973792.5A patent/CN105362675A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110778A (zh) * | 2013-02-21 | 2013-05-22 | 遵义市时慧母婴保健护理有限公司 | 一种治疗急性乳腺炎的外用中药散剂配方及制备方法 |
| CN103860855A (zh) * | 2014-03-01 | 2014-06-18 | 王树军 | 一种用于治疗乳痈的中药 |
| CN104288700A (zh) * | 2014-10-27 | 2015-01-21 | 合肥丰瑞隆生物科技有限公司 | 一种治疗乳腺炎的外敷中药 |
| CN104623220A (zh) * | 2015-03-09 | 2015-05-20 | 崔合芳 | 一种治疗乳痈的中药组合物及其应用 |
| CN104623612A (zh) * | 2015-03-09 | 2015-05-20 | 王艳君 | 一种治疗乳痈的活血化瘀药及制备方法 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107569556A (zh) * | 2017-10-07 | 2018-01-12 | 南京正宽医药科技有限公司 | 一种乳腺炎护理药物组合物及其制备方法 |
| CN118045022A (zh) * | 2024-01-03 | 2024-05-17 | 广州润华生命科学有限公司 | 一种具有促渗透功效的植物组合物及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
| CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
| CN102755446A (zh) | 一种茶油烧伤膏及其制备方法 | |
| CN101518600B (zh) | 一种治疗细菌或真菌性皮肤病的中药组合物及其制备方法 | |
| CN106620539A (zh) | 治疗皮肤病的外用药膏、制备方法及其应用 | |
| CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
| CN104857290A (zh) | 一种治疗烧烫伤的中药消毒膏及其制备方法 | |
| CN104840635A (zh) | 一种缓解眼疲劳的中草药滴眼液及其制备方法 | |
| CN106581439A (zh) | 一种治疗创伤、糖尿病足和皮肤溃烂的中药组合物及其制备方法 | |
| CN102940831A (zh) | 一种用于抑菌与治疗妇科炎症的外用泡腾片 | |
| CN105056159A (zh) | 一种治疗猪寄生虫病的药物及其制备方法 | |
| CN105662996A (zh) | 治疗月经相关性痤疮的中药面膜 | |
| CN103933405A (zh) | 用于治疗气血两虚型烧伤的药物组合物及其制备方法 | |
| CN105362675A (zh) | 一种治疗粉刺性乳痈的乳膏及其制备方法 | |
| CN104147516A (zh) | 一种治疗骨髓炎的中药组方 | |
| CN107789525A (zh) | 一种治疗臁疮溃疡多年不愈的药物及其制备方法 | |
| CN105362516A (zh) | 一种治疗粉刺性乳痈的酊剂及其制备方法 | |
| CN105327244A (zh) | 一种含有艾叶的治疗褥疮的中药组合物及其制备方法 | |
| CN104922449A (zh) | 一种中药消毒液及其制备方法 | |
| CN105456957A (zh) | 一种治疗狐臭的中药组合物 | |
| CN105311600A (zh) | 具有杀菌消毒功效的医用凝胶 | |
| CN104623304A (zh) | 一种治疗湿热毒蕴型慢性皮肤溃疡的洗剂及其制备方法 | |
| CN104491371A (zh) | 慢性乳腺结核消肿散结膏及制备方法 | |
| CN104587076A (zh) | 一种治疗结膜炎的中药洗液 | |
| CN105106774B (zh) | 一种用于会阴护理的中药护理包及其制备方法和中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160302 |
|
| RJ01 | Rejection of invention patent application after publication |